文献速递急性肾损伤

β-羟丁酸通过抗焦亡效应减轻肾脏缺血再灌注损伤

β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects.
PubMed 文献 · Kidney Int · 2019-02-28

该研究在小鼠肾缺血再灌注损伤(IRI)模型中,通过渗透泵持续输注β-羟丁酸(β-OHB)或禁食升高内源性β-OHB,发现β-OHB可减轻肾IRI,减少TUNEL阳性细胞、增加FOXO3表达、降低caspase-1和促炎细胞因子,提示其通过抗焦亡效应及表观遗传调控FOXO3发挥保护作用。

要点

  • β-OHB输注或禁食升高内源性β-OHB均可减轻小鼠肾IRI。
  • β-OHB减少焦亡标志物caspase-1和促炎细胞因子,不改善凋亡标志物。
  • β-OHB通过抑制HDAC恢复FOXO3启动子组蛋白乙酰化,且停输后保护效应仍存在。

核心结论

  • β-OHB通过抗焦亡效应减轻肾脏IRI,可能由表观遗传调控FOXO3表达介导。

研究设计与样本

  • 小鼠肾IRI模型,通过渗透泵持续输注β-OHB或禁食升高内源性β-OHB。
  • 体外使用人近端小管细胞系暴露于缺氧复氧,并给予β-OHB处理。

主要发现

  • β-OHB治疗较生理盐水对照减轻肾IRI,禁食条件结果相似。
  • β-OHB减少TUNEL阳性细胞并增加FOXO3表达。
  • β-OHB不影响凋亡标志物,但降低caspase-1和促炎细胞因子表达。
  • 在缺氧复氧的人近端小管细胞中,β-OHB以FOXO3依赖方式减少细胞死亡。
  • IRI肾脏及缺氧复氧细胞中组蛋白乙酰化降低,β-OHB通过抑制HDAC改善;体外β-OHB恢复FOXO3启动子组蛋白乙酰化。

临床怎么用

  • 提示β-OHB/生酮状态可能作为减轻肾IRI的潜在策略,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ketone bodies including β-hydroxybutyrate (β-OHB) have been shown to protect against ischemic tissue injury when present at low concentrations. We evaluated the impact of β-OHB on renal ischemia/reperfusion injury (IRI). Mice were treated with a continuous infusion of β-OHB using an osmotic mini-pump before and after IRI. We also tested the effects of increasing endogenous serum β-OHB levels by fasting. Renal IRI was attenuated by β-OHB treatment compared to saline control, with similar results in the fasting condition. β-OHB treatment reduced the number of terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive cells and increased expression of forkhead transcription factor O3 (FOXO3), an upstream regulator of pyroptosis. Although β-OHB treatment did not impact markers of apoptosis, it decreased the expression of caspase-1 and proinflammatory cytokines, indicating that β-OHB blocked pyroptosis. In a human proximal tubular cell line exposed to hypoxia and reoxygenation, β-OHB reduced cell death in a FOXO3-dependent fashion. Histone acetylation was decreased in kidneys exposed to IRI and in proximal tubular cells exposed to hypoxia and reoxygenation, and this effect was ameliorated by β-OHB through the inactivation of histone deacetylases. In vitro, β-OHB treatment restored histone acetylation at the FOXO3 promoter. Consistent with epigenetic molecular effects, the renoprotective effects of β-OHB were still observed when the continuous infusion was stopped at the time of IRI. Thus, β-OHB attenuates renal IRI through anti-pyroptotic effects, likely mediated by an epigenetic effect on FOXO3 expression.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Tajima T, Yoshifuji A, Matsui A, et al. β-hydroxybutyrate attenuates renal ischemia-reperfusion injury through its anti-pyroptotic effects. Kidney Int. 2019. PMID: 30826015. doi:10.1016/j.kint.2018.11.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。